Paragon Partners has sold Anti-Germ to Hypred
Lincoln International is pleased to announce that PARAGON PARTNERS, sole shareholder of Anti-Germ International GmbH (“Anti-Germ”) has sold its shares in Anti-Germ to Hypred, a portfolio company of Ardian Mid Cap Buyout.
Anti-Germ, founded in 1938, is a European leader in the provision of disinfection and biosafety solutions especially for the food, beverage and agricultural markets. Anti-Germ is also involved in the disinfection of water with its brand Medentech. Anti-Germ is present in 16 countries worldwide and has 8 industrial sites in France, Germany, Austria, Poland, Hungary, Ireland, China and Turkey. In 2016, Anti-Germ achieved a turnover of Euro 80 million.
Hypred established in 1985, benefits from solid industrial expertise in the formulation, production and marketing of biosafety, disinfection and hygiene solutions for the food industry and agriculture professionals. Hypred is present in more than 40 countries and employs more than 400 people. Hypred benefits from a first-class industrial device enabling it to work with its customers throughout the world. Its own production sites and partner companies are located, among others, in France, Spain, Italy, Germany, Poland, Argentina, Brazil, Colombia, Peru, Turkey, United States and South Africa. In 2015, Hypred achieved a turnover of more than Euro 100 million.
The critical size of the planned merged group provides a solid basis to face the increasing requirements of the regulatory authorities in order to take full advantage of the steady and resilient market growth. The industry is currently experiencing a number of changes, including increasing safety standards, a need for the prevention of epidemics, strategies to reduce the use of antibiotics as well as traceability and productivity requirements. Geographically, the two companies will strengthen their presence in Europe with wider coverage and a denser network of territories.
Dr. Edin Hadzic, founding Partner at PARAGON PARTNERS, commented “We are grateful for having the opportunity to support the transformation of Anti-Germ. We are proud of the development of Anti-Germ as an independent company. We are pleased to announce that Anti-Germ found in Hypred a strong partner to further drive the next step of growth. The merger of the two highly complementary companies creates considerable opportunities for employees as well as for customers. We wish all parties concerned a successful future.”
Matthias Kötter, CEO of Anti-Germ, explains, “With the support of our shareholder, Paragon Partners, we have transformed Anti-Germ into an independent firm and become the market leader for hygiene in the agriculture, food and beverage sector. We are very pleased to now partner with Hypred, one of the key players in our industry, to start the next phase of growth.”
Lincoln International acted as the exclusive financial advisor to Paragon Partners and supported on the due diligence and contract negotiation. The parties have agreed not to comment on any transaction details.
Meet our Senior Team
View More Transactions
Lincoln International has advised Airsweb on its sale to EcoOnline, a Norway-based company backed by Goldman Sachs, Summa Equity and Viking Venture
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that Sparton Corporation, a portfolio company of Cerberus Capital Management, L.P. (together with its affiliates, “Cerberus”), has sold its manufacturing and design services division (“MDS”) to One Equity Partners
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack